Market Overview

UPDATE: Raymond James Upgrades Becton, Dickinson & Company from Underperform to Market Perform

Share:
Related BDX
Earnings Scheduled For November 2, 2017
Benzinga's Top Upgrades, Downgrades For September 22, 2017
Becton Dickinson: A Fully Valued Healthcare Blue Chip Stock (Seeking Alpha)

In a research note published Wednesday, Raymond James upgraded Becton, Dickinson and Company (NYSE: BDX) from Underperform to Market Perform.

The firm's Lawrence Keusch noted Becton, Dickinson and Company's business has stabilized and this is reflected in the solid Q1 results.

Keusch also believes that shares of BDX will perform inline with the market citing a valuation reflecting improved fundamentals and numerous defensive qualities in its business profile, which are likely to be favored in the current equity market.

BDX's shares are currently up 0.77 percent trading around $106.71.

Latest Ratings for BDX

DateFirmActionFromTo
Nov 2017Morgan StanleyMaintainsEqual-Weight
Oct 2017Wells FargoMaintainsOutperform
Sep 2017Wells FargoInitiates Coverage OnOutperform

View More Analyst Ratings for BDX
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (BDX)

View Comments and Join the Discussion!

Partner Center